Sequential Fabrication of a Three-Layer Retina-like Structure.

3D bio-printing age-related macular degeneration retina tissue engineering

Journal

Gels (Basel, Switzerland)
ISSN: 2310-2861
Titre abrégé: Gels
Pays: Switzerland
ID NLM: 101696925

Informations de publication

Date de publication:
15 May 2024
Historique:
received: 11 04 2024
revised: 24 04 2024
accepted: 12 05 2024
medline: 24 5 2024
pubmed: 24 5 2024
entrez: 24 5 2024
Statut: epublish

Résumé

Tissue engineering is considered a promising approach to treating advanced degenerative maculopathies such as nonexudative age-related macular degeneration (AMD), the leading cause of blindness worldwide. The retina consists of several hierarchical tissue layers, each of which is supported by a layer underneath. Each of these layers has a different morphology and requires distinct conditions for proper assembly. In fact, a prerequisite step for the assembly of each of these layers is the organization of the layer underneath. Advanced retinal degeneration includes degeneration of the other retina layers, including the choroid, the retinal pigmented epithelium (RPE), and the photoreceptors. Here, we report a step-by-step fabrication process of a three-layer retina-like structure. The process included the 3D printing of a choroid-like structure in an extracellular matrix (ECM) hydrogel, followed by deposition of the RPE monolayer. After the formation of the blood vessel-RPE interface, the photoreceptor cells were deposited to interact with the RPE layer. At the end of the fabrication process, each layer was characterized for its morphology and expression of specific markers, and the integration of the three-layer retina was evaluated. We envision that such a retina-like structure may be able to attenuate the deterioration of a degenerated retina and improve engraftment and regeneration. This retinal implant may potentially be suitable for a spectrum of macular degenerative diseases for which there are currently no cures and may save millions from complete blindness.

Identifiants

pubmed: 38786253
pii: gels10050336
doi: 10.3390/gels10050336
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : CSRD VA
ID : 1
Pays : United States

Auteurs

Yahel Shechter (Y)

Shmunis School of Biomedicine and Cancer Research, Faculty of Life Science, Tel Aviv University, Tel Aviv 6997801, Israel.

Roni Cohen (R)

Shmunis School of Biomedicine and Cancer Research, Faculty of Life Science, Tel Aviv University, Tel Aviv 6997801, Israel.
Department of Biomedical Engineering, Faculty of Engineering, Tel Aviv University, Tel Aviv 6997801, Israel.
Sagol School of Neuroscience, Tel Aviv University, Tel Aviv 6997801, Israel.

Michael Namestnikov (M)

Shmunis School of Biomedicine and Cancer Research, Faculty of Life Science, Tel Aviv University, Tel Aviv 6997801, Israel.

Assaf Shapira (A)

Shmunis School of Biomedicine and Cancer Research, Faculty of Life Science, Tel Aviv University, Tel Aviv 6997801, Israel.

Adiel Barak (A)

Division of Ophthalmology, Tel Aviv Medical Center, Tel Aviv 6423906, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.

Aya Barzelay (A)

Division of Ophthalmology, Tel Aviv Medical Center, Tel Aviv 6423906, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.

Tal Dvir (T)

Shmunis School of Biomedicine and Cancer Research, Faculty of Life Science, Tel Aviv University, Tel Aviv 6997801, Israel.
Department of Biomedical Engineering, Faculty of Engineering, Tel Aviv University, Tel Aviv 6997801, Israel.
Sagol School of Neuroscience, Tel Aviv University, Tel Aviv 6997801, Israel.
The Center for Nanoscience and Nanotechnology, Tel Aviv University, Tel Aviv 6997801, Israel.
Sagol Center for Regenerative Biotechnology, Tel Aviv University, Tel Aviv 6997801, Israel.

Classifications MeSH